Ivanna and her Singapore-based partner Kane Black are committed to empowering patients and physicians through research, development and commercialisation of blood-based tests. They have pushed for rapid and accurate detection of cancer based on Asian-specific epigenetic biomarkers through the company’s test NovoTect Bc, the first to focus on Asian patients.